Yiqi Formula Enhances the Antitumor Effects of Erlotinib for Treatment of Triple-Negative Breast Cancer Xenografts

Figure 2

(a) Tumor growth (volume) with time. (b) The selected tumor samples of each group from mice on day 50.

(a)

(b)